Document Detail

Topiramate prophylaxis and response to triptan treatment for acute migraine.
MedLine Citation:
PMID:  17040339     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate the effect of topiramate migraine prophylaxis on subject responsiveness to triptans used for acute symptomatic migraine treatment. BACKGROUND: Clinical experience suggests that prophylactic migraine treatment may enhance the efficacy of symptomatic medications used to treat acute migraine attacks. METHODS: This open-label, single-arm multicenter study consisted of a 6-week baseline period followed by a 16-week topiramate treatment period. Subjects meeting International Headache Society (IHS) criteria for migraine with and without aura signed consent and entered the baseline period. Those with 3 to 12 migraine periods per month during baseline received topiramate prophylactic treatment. Only patients who completed at least 12 weeks of topiramate treatment were included in the data analysis. RESULTS: Of 55 patients screened, 40 subjects entered the topiramate treatment period and 21 subjects received at least 12 weeks of treatment. Mean final dose of topiramate was 124 mg per day (range 50 to 200 mg per day). During the baseline period, the mean percentage of attacks rendered pain-free at 2 hours for the 21 subjects was 46.9% (SD = 31.9), while during the topiramate treatment period it was 44.6% (SD = 32.2) (P= .8). On topiramate, after the first 8 weeks of dosage titration, patients experienced a mean of 3.68 migraine attacks/month, compared to 4.31 during the baseline period (P < .03). Thirteen subjects discontinued because of adverse events. The most commonly reported adverse events were paresthesia, fatigue, anxiety, and dizziness. CONCLUSION: Although topiramate prophylaxis did reduce migraine attack frequency, in this pilot study topiramate prophylactic migraine treatment did not increase the proportion of patients pain-free 2 hours after symptomatic triptan therapy.
Werner J Becker; Suzanne N Christie; Stephane Ledoux; Carin Binder
Related Documents :
21440289 - Does timing of presentation of penile fracture affect outcome of surgical intervention?
18591129 - Long term role of pergolide as an adjunct therapy in parkinson's disease: influence on ...
21336149 - Effect of a failed trabectome on subsequent trabeculectomy.
12730989 - Randomized trial of pallidotomy versus medical therapy for parkinson's disease.
25250699 - Intra-articular hip injection and early revision following total hip arthroplasty: a re...
18272089 - Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rat...
2040339 - The ape nebuliser--a new delivery system for the alveolar targeting of particulate tech...
22907609 - No benefit from perioperative intravenous lidocaine in laparoscopic renal surgery: a ra...
22203789 - Seasonal abundance and suppression of fruit-piercing moth eudocima phalonia (l.) in a c...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Headache     Volume:  46     ISSN:  0017-8748     ISO Abbreviation:  Headache     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-16     Completed Date:  2007-01-23     Revised Date:  2009-02-02    
Medline Journal Info:
Nlm Unique ID:  2985091R     Medline TA:  Headache     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1424-30     Citation Subset:  IM    
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anxiety Disorders / complications,  epidemiology
Chronic Disease
Headache / complications*,  epidemiology
Mood Disorders / complications,  epidemiology
Pain / complications*,  epidemiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The comorbidity of headache with other pain syndromes.
Next Document:  Visual stimuli are common triggers of migraine and are associated with pattern glare.